October 25, 2016 4:25 AM ET


Company Overview of Kite Pharma, Inc.

Executive Profile

Roy Doumani J.D., MBA

Independent Director and Member of Nominating & Corporate Governance Committee, Kite Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 Board Members in 11 different organizations across 10 different industries.

See Board Relationships


Mr. Roy Doumani, J.D., MBA, is the Chief Operating Officer at the California NanoSystems Institute. Mr. Doumani continues his involvement in real estate as a Partner in The Hills. For the past two decades, he has held positions both as a Principal and Director of banking and real estate institutions. Mr. Doumani is also a Professor of Molecular and Medical Pharmacology at the David Geffen School of Medicine. He was the Venture Partner at Fulcrum Capital Group, LLC. Mr. ...

Corporate Headquarters

2225 Colorado Avenue
Santa Monica, California 90404

United States

Phone: 310-824-9999
Fax: --

Board Members Memberships

Member of Advisory Board
Representative Director and Member of Strategy Committee
Director and Advisory Board Member
Board Member
Vice Chairman, Chairman of Compensation Committee, Member of Audit Committee, Member of Corporate Governance Committee, and Member of Stock Option Committee
Independent Director and Member of Nominating & Corporate Governance Committee


University of Southern California
University of California-Los Angeles

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$44,125
Total Calculated Compensation$423,948

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kite Pharma, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.